Press Releases

Veeva Systems and Bioforum announced their collaboration with RedHill Biopharma Ltd. on a global Phase 2/3 clinical study evaluating opaganib (Yeliva®, ABC294640),1 a first-in-class, orally-administered, sphingosine kinase-2 (SK2) selective inhibitor, in patients hospitalized with severe COVID-19 pneumonia requiring treatment...

Turkish Cargo, the global air cargo brand that has digitalized its business processes, provides convenience to its customers in its global network and continues its journey to the future by integrating the virtual workforce Robotic Process Automations (RPA) that...

Pharmaspectra, the world’s largest collection of medical science, announced it has entered into a partnership with IBM Watson Health. Through the partnership agreement, IBM Watson Health is withdrawing IBM Stakeholder Manager® from its portfolio and offering a transition path for...

Informa Markets, the organisers of the leading regional pharmaceutical event CPhI Middle East & Africa, (CPhI MEA), has announced the 2020 edition of the show will be held alongside the Global Health Exhibition (GHE) in Riyadh, Saudi Arabia on...

Johnson & Johnson announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for its COVID-19 vaccine candidate, JNJ-78436735, being developed by its Janssen Pharmaceutical Companies. The initiation of the ENSEMBLE trial follows positive interim results from...

Sanofi and GSK have signed agreements with the Government of Canada for the supply of up to 72 million doses of an adjuvanted COVID-19 vaccine, beginning in 2021. “Today’s announcement showcases our unwavering commitment to develop a COVID-19 vaccine that...

Sun Pharmaceutical Industries Limited and includesits subsidiaries and/or associate companies) announced that its wholly-owned Japanese subsidiary has launched ILUMYA® Subcutaneous Injection 100 mg Syringe (Nonproprietary name: tildrakizumab(genetical recombination), “ILUMYA”) in Japan for the treatment of plaque psoriasis in adult...